James Sun

9PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 10, 2025
Effect of Rectal Cancer Treatment Timing Standardization on Patient Outcomes.

James Sun, Jordan D Fredette, Jill S Hasler

|Feb 10, 2024
The Use of Gene Expression Profiling and Biomarkers in Melanoma Diagnosis and Predicting Recurrence: Implications for Surveillance and Treatment.

James Sun, Kameko M Karasaki, Jeffrey M Farma

|Sep 30, 2021
Real-world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia.

James Sun, Xiaojun Zhong, Junjie Ma

|Aug 22, 2020
Observational study of talimogene laherparepvec use in the anti-PD-1 era for melanoma in the US (COSMUS-2).

James Sun, Brian R Gastman, Lucy McCahon

|Mar 13, 2020
Isolated limb infusion: Institutional protocol and implementation.

Michael J Carr, James Sun, Jonathan S Zager

|Dec 08, 2019
Perioperative Outcomes of Melanoma Patients Undergoing Surgery After Receiving Immunotherapy or Targeted Therapy.

James Sun, Dennis A Kirichenko, Joyce L Chung

Pageof 2

Frequent Collaborators

2 joint publications

Jonathan S Zager

1 joint publications

Dale Han

1 joint publications

Deepak Narayan

1 joint publications

Michael Lowe